Literature DB >> 23369303

A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences.

J Natalia Jiménez1, Ana M Ocampo, Johanna M Vanegas, Erika A Rodriguez, José R Mediavilla, Liang Chen, Carlos E Muskus, Lázaro A Vélez, Carlos Rojas, Andrea V Restrepo, Carlos Garcés, Barry N Kreiswirth, Margarita M Correa.   

Abstract

Most studies on Staphylococcus aureus have focused on the molecular epidemiology of methicillin-resistant S. aureus (MRSA) infections. In contrast, little information is available regarding the molecular epidemiology of currently circulating methicillin-susceptible S. aureus (MSSA) isolates in hospital settings, an epoch when the epidemiology of S. aureus has undergone significant changes. We conducted a cross-sectional study to compare the clinical, epidemiological, and genetic characteristics of MSSA and MRSA isolates at 3 tertiary-care hospitals in Medellín, Colombia, from February 2008 to June 2010. The infections were classified according to the Centers for Disease Control and Prevention (CDC) definitions. Genotypic analysis included spa typing, multilocus sequence typing (MLST) and staphylococcal cassette chromosome (mec) (SCCmec) typing. A total of 810 patients was enrolled. One hundred infections (12.3%) were classified as community-associated (31 CA-MSSA, 69 CA-MRSA), 379 (46.8%) as healthcare-associated community-onset (136 HACO-MSSA, 243 HACO-MRSA), and 331 (40.9%) as healthcare-associated hospital-onset (104 HAHO-MSSA, 227 HAHO-MRSA). Genotype analyses showed a higher diversity and a more varied spa type repertoire in MSSA than in MRSA strains. Most of the clinical-epidemiological characteristics and risk factors evaluated did not allow for discriminating MRSA- from MSSA-infected patients. The lack of equivalence among the genetic backgrounds of the major MSSA and MRSA clones would suggest that the MRSA clones are imported instead of arising from successful MSSA clones. This study emphasizes the importance of local surveillance to create public awareness on the changing S. aureus epidemiology.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23369303     DOI: 10.1016/j.ijmm.2012.12.003

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  9 in total

1.  Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.

Authors:  Y M Wi; J Y Rhee; C I Kang; D R Chung; J H Song; K R Peck
Journal:  Epidemiol Infect       Date:  2018-05-21       Impact factor: 4.434

2.  Differences in epidemiological and molecular characteristics of nasal colonization with Staphylococcus aureus (MSSA-MRSA) in children from a university hospital and day care centers.

Authors:  Erika A Rodríguez; Margarita M Correa; Sigifredo Ospina; Santiago L Atehortúa; J Natalia Jiménez
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

3.  Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children.

Authors:  Yanhong Qiao; Xue Ning; Qiang Chen; Ruizhen Zhao; Wenqi Song; Yuejie Zheng; Fang Dong; Shipeng Li; Juan Li; Lijuan Wang; Ting Zeng; Yanhong Dong; Kaihu Yao; Sangjie Yu; Yonghong Yang; Xuzhuang Shen
Journal:  BMC Infect Dis       Date:  2014-11-07       Impact factor: 3.090

4.  Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.

Authors:  Jessica E Ericson; Victor O Popoola; P Brian Smith; Daniel K Benjamin; Vance G Fowler; Daniel K Benjamin; Reese H Clark; Aaron M Milstone
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 26.796

Review 5.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

6.  Synergistic activity and mechanism of action of Stephania suberosa Forman extract and ampicillin combination against ampicillin-resistant Staphylococcus aureus.

Authors:  Yothin Teethaisong; Nongluk Autarkool; Kittipot Sirichaiwetchakoon; Pongrit Krubphachaya; Sajeera Kupittayanant; Griangsak Eumkeb
Journal:  J Biomed Sci       Date:  2014-09-11       Impact factor: 8.410

Review 7.  Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.

Authors:  Parisa Asadollahi; Narges Nodeh Farahani; Mehdi Mirzaii; Seyed Sajjad Khoramrooz; Alex van Belkum; Khairollah Asadollahi; Masoud Dadashi; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2018-02-12       Impact factor: 5.640

Review 8.  Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review.

Authors:  Rodrigo Cuiabano Paes Leme; Paulo José Martins Bispo; Mauro José Salles
Journal:  Braz J Infect Dis       Date:  2021-02-16       Impact factor: 3.257

9.  In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid.

Authors:  Johanna Marcela Vanegas Múnera; Ana María Ocampo Ríos; Daniela Montoya Urrego; Judy Natalia Jiménez Quiceno
Journal:  Braz J Infect Dis       Date:  2017-04-19       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.